Open AccessLepra recurrent developed after termination of antileprotic therapy
Author(s) -
А. А. Кубанов,
А. Э. Карамова,
Victoria G. Semyonova,
В А Смольянникова,
М. А. Нефедова
Publication year - 2016
Publication title -
vestnik dermatologii i venerologii
Language(s) - English
Resource type - Journals
eISSN - 2313-6294
pISSN - 0042-4609
DOI - 10.25208/0042-4609-2016-92-6-66-72
Subject(s) - medicine , leprosy , disease , mycobacterium leprae , dermatology , pediatrics , surgery , pathology
Lepra is an infectious disease, granulomatosis caused by Mycobacterium leprae. It is characterized with prolonged latent period (from 3-5 years to several decades), low transmission, generally lesions of skin and peripheral nervous system. The recurrent of disease is possible after the termination of antileprotic therapy. A case report presented demonstrating the lepra recurrent in female patient 4 years after termination of therapy; that was conducted during 17 years and led to the regression of clinical symptoms and to negative results of bacterioscopic examination of nasal brushings and scratch samples from sites of former eruptions. This case should call attention of dermatologists and other physicians to the problem of leprosy recurrent diagnosis in previously observed and deregistered patients.